AstraZeneca Pharma India receives permission from CDSCO to import new drug
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Decision on EU marketing authorisation expected for momelotinib by early 2024
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Subscribe To Our Newsletter & Stay Updated